Signalling pathways in pemphigus vulgaris
- PMID: 24387643
- DOI: 10.1111/exd.12317
Signalling pathways in pemphigus vulgaris
Abstract
Acantholysis in pemphigus vulgaris is induced by binding of autoantibodies to desmoglein 3 (Dsg3). The roles of signalling pathways on development of acantholysis have recently been extensively studied. In the study by Sayar et al., recently published in Exp Dermatol, epidermal growth factor receptor (EGFR) signalling was activated in both in vivo and in vitro pemphigus vulgaris experimental models. However, while EGFR inhibitors suppressed activity of p38 mitogen-activated protein kinase (p38MAPK) linearly, they suppressed activity of c-Myc and acantholysis in a non-linear, V-shaped relationship. These findings indicated complicated interactions among EGFR, p38MAPK and c-Myc in pemphigus vulgaris pathology.
Keywords: acantholysis; pemphigus vulgaris; signalling pathway.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Comment on
-
EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non-linear, V-shaped relationship.Exp Dermatol. 2014 Jan;23(1):33-8. doi: 10.1111/exd.12290. Exp Dermatol. 2014. PMID: 24279293
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
